Source comparison
GHRP-2 Acetate vs Ipamorelin: Research Application Comparison
GH Release Magnitude 4–6× baseline at 200 mcg dose Comparable GH stimulation at equimolar doses Cortisol Elevation +20–35% above baseline <5% variation from baseline GHRP-2 confounds cortisol-sensitive metabolic outcomes Prolactin Elevation +15–25% above basel
This comparison does not assign a generated winner or score.
- GH Release Magnitude
- 4–6× baseline at 200 mcg dose
- Comparable GH stimulation at equimolar doses
- Cortisol Elevation
- +20–35% above baseline
- <5% variation from baseline
- GHRP-2 confounds cortisol-sensitive metabolic outcomes
- Prolactin Elevation
- +15–25% above baseline
- Ipamorelin avoids reproductive/endocrine confounders
- Plasma Half-Life
- 20–30 minutes
- Both require multiple daily doses for sustained effect
- Peak GH Response Time
- 30–45 minutes post-injection
- 45–60 minutes post-injection
- Ipamorelin shows slightly delayed but longer pulse
- Appetite Stimulation
- Mild dose-dependent effect
- None observed at standard doses
- GHRP-2 may confound food intake studies
- Receptor Selectivity
- Moderate (activates GHS-R1a + secondary pathways)
- High (selective GHS-R1a without ACTH/prolactin activation)
- Ipamorelin isolates GH variable more cleanly
- Bottom Line
- Better for multi-hormone stress response models
- Better for isolated GH research without endocrine confounders
- Choose based on whether secondary hormones serve or confound your experimental question